| Ident. | Authors (with country if any) | Title |
|---|
| 000021 (2020) |
Jumpei Temmoku [Japon] ; Yuya Fujita [Japon] ; Naoki Matsuoka [Japon] ; Takeshi Urano [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Shuzo Sato [Japon] ; Haruki Matsumoto [Japon] ; Hiroshi Watanabe [Japon] ; Hideko Kozuru [Japon] ; Hiroshi Yatsuhashi [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon] | Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib. |
| 000168 (2020) |
Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] | Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan |
| 000298 (2020) |
Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon] | Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. |
| 000372 (2020) |
Michie Imamura ; Akihiro Mukaino ; Koutaro Takamatsu ; Hiroto Tsuboi ; Osamu Higuchi ; Hideki Nakamura ; Saori Abe ; Yukio Ando ; Hidenori Matsuo ; Tadashi Nakamura ; Takayuki Sumida ; Atsushi Kawakami ; Shunya Nakane | Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases |
| 000586 (2020) |
Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami | An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance |
| 000899 (2019) |
Ryuki Sakaguchi [Japon] ; Keita Fujikawa [Japon] ; Momoko Okamoto [Japon] ; Emi Matsuo [Japon] ; Kohei Matsumoto [Japon] ; Tomohisa Uchida [Japon] ; Kawashiri Shin-Ya [Japon] ; Masahiro Nakashima [Japon] ; Akinari Mizokami [Japon] ; Atsushi Kawakami [Japon] | Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder |
| 000C65 (2019) |
Tomohisa Uchida ; Momoko Okamoto ; Keita Fujikawa ; Daisuke Yoshikawa ; Akinari Mizokami ; Tomo Mihara ; Akira Kondo ; Kazuo Ohba ; Kazuhiro Kurohama ; Masahiro Nakashima ; Ichiro Sekine ; Shigeki Nakamura [Japon] ; Yoshitsugu Miyazaki [Japon] ; Atsushi Kawakami [Japon] | Gastric mucormycosis complicated by a gastropleural fistula |
| 000D22 (2019) |
Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Manabu Iwasaki [Japon] ; Kou Katayama [Japon] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] ; Désirée Van Der Heijde [Pays-Bas] | Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan |
| 000F47 (2019) |
Erika Aikawa [Japon] ; Toshimasa Shimizu [Japon] ; Tomohiro Koga [Japon] ; Yushiro Endo [Japon] ; Masataka Umeda [Japon] ; Tomoko Hori [Japon] ; Junji Irie [Japon] ; Kishio Kuroda [Japon] ; Mizuna Eguchi [Japon] ; Momoko Okamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Remi Sumiyoshi [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Atsushi Kawakami [Japon] | Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab. |
| 001024 (2019) |
Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon] | A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. |
| 001390 (2018) |
Masataka Umeda [Japon] ; Tomohiro Koga [Japon] ; Kunihiro Ichinose [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Toshimasa Shimizu [Japon] ; Shoichi Fukui [Japon] ; Ayako Nishino [Japon] ; Yoshiro Horai [Japon] ; Yasuko Hirai [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Toshiyuki Aramaki [Japon] ; Yukitaka Ueki [Japon] ; Akitomo Okada [Japon] ; Keita Fujikawa [Japon] ; Naoki Matsuoka [Japon] ; Atsushi Kawakami [Japon] | Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice. |
| 001442 (2018) |
Tomohiro Koga [Japon] ; Shuntaro Sato [Japon] ; Junya Miyamoto [Japon] ; Naoko Hagimori [Japon] ; Yurika Kawazoe [Japon] ; Kumiko Arinaga [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami [Japon] | Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial. |
| 001601 (2017) |
Masataka Umeda [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Kaoru Terada [Japon] ; Gou Takeo [Japon] ; Nobuhisa Yonemitsu [Japon] ; Yukitaka Ueki [Japon] ; Kiyoshi Migita [Japon] ; Atsushi Kawakami [Japon] | Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis. |
| 001827 (2017) |
Naoki Iwamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Toshimasa Shimizu [Japon] ; Shoichi Fukui [Japon] ; Masataka Umeda [Japon] ; Ayako Nishino [Japon] ; Yoshiro Horai [Japon] ; Tomohiro Koga [Japon] ; Shin-Ya Kawashiri [Japon] ; Toshiyuki Aramaki [Japon] ; Kunihiro Ichinose [Japon] ; Yasuko Hirai [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Kaoru Terada [Japon] ; Tomoki Origuchi [Japon] ; Katsumi Eguchi [Japon] ; Yukitaka Ueki [Japon] ; Atsushi Kawakami [Japon] | Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis. |
| 001926 (2017) |
Jin Nakagawa [Japon] ; Yoshinobu Koyama [Japon] ; Atsushi Kawakami [Japon] ; Yukitaka Ueki [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Shuji Nagano [Japon] ; Ayumi Uchino [Japon] ; Toshiyuki Ota [Japon] ; Mitsuteru Akahoshi [Japon] ; Koichi Akashi [Japon] | A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study. |
| 001B60 (2016) |
Shinichiro Tsurukawa [Japon] ; Nozomi Iwanaga [Japon] ; Yasumori Izumi [Japon] ; Atsunori Shirakawa [Japon] ; Chieko Kawahara [Japon] ; Tetsuo Shukuwa [Japon] ; Miwako Inamoto [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon] | Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease. |
| 001B74 (2016) |
Shoichi Fukui [Japon] ; Naoki Iwamoto [Japon] ; Toshimasa Shimizu [Japon] ; Masataka Umeda [Japon] ; Ayako Nishino [Japon] ; Tomohiro Koga [Japon] ; Shin-Ya Kawashiri [Japon] ; Kunihiro Ichinose [Japon] ; Yasuko Hirai [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Toshiyuki Aramaki ; Nozomi Iwanaga ; Yasumori Izumi ; Tomoki Origuchi [Japon] ; Kiyoshi Migita ; Yukitaka Ueki ; Shuntaro Sato [Japon] ; Atsushi Kawakami [Japon] | Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years |
| 001B80 (2016) |
Naoki Iwamoto [Japon] ; Shoichi Fukui [Japon] ; Masataka Umeda [Japon] ; Ayako Nishino [Japon] ; Yoshikazu Nakashima [Japon] ; Takahisa Suzuki [Japon] ; Yoshiro Horai [Japon] ; Fumiaki Nonaka [Japon] ; Akitomo Okada [Japon] ; Tomohiro Koga [Japon] ; Shin-Ya Kawashiri [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki ; Kunihiro Ichinose [Japon] ; Yasuko Hirai [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Kaoru Terada ; Munetoshi Nakashima [Japon] ; Akinari Mizokami [Japon] ; Tomoki Origuchi [Japon] ; Katsumi Eguchi [Japon] ; Yukitaka Ueki ; Atsushi Kawakami [Japon] | Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis. |
| 001C53 (2016) |
Tomohiro Koga ; Kiyoshi Migita ; Atsushi Kawakami | Biologic therapy in familial Mediterranean fever. |
| 001F70 (2015) |
Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira Nomura | Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study. |
| 002076 (2015) |
Shin-Ya Kawashiri [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Akitomo Okada [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Kazuhiko Arima [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Masataka Uetani [Japon] ; Kiyoshi Aoyagi [Japon] ; Atsushi Kawakami [Japon] | Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients. |
